2.365USD-0.95%Mkt Cap: 7.31M USDP/E: —Last update: 2026-06-01
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worl…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap7.31M USD
Enterprise Value6.24M USD
Revenue (TTM)4.33M USD
Gross Profit498.00K USD
Net Income (TTM)-4.97M USD
Revenue/Share1.608 USD
Last Price2.365 USD
Fiscal Year EndMay 2025
MR QuarterFeb 2026
Employees53
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)6.12
PEG—
EV/EBITDA-1.18
EV/Revenue1.44
P/S1.71
P/B2.18
EPS (TTM)-1.61
EPS (Forward)0.39
52W Range
1.87018% of range4.600
52W High4.600 USD
52W Low1.870 USD
Profitability
Gross Margin9.38%
Oper. Margin-131.51%
EBITDA Margin-121.75%
Profit Margin-93.64%
ROE-121.14%
ROA-83.65%
Growth
Revenue Growth-11.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.84M USD
CapEx (TTM)37.00K USD
FCF Margin-46.88%
FCF Yield-27.75%
Net Debt-1.14M USD
Net Debt/EBITDA0.22
Balance Sheet
Debt/Equity0.11
Current Ratio2.64
Quick Ratio1.46
Book Value/Sh1.095 USD
Cash/Share0.4320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateApr 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.09M
Float2.77M
Insiders15.24%
Institutions3.62%
Short Interest
Short Ratio4.8d
Short % Float3.34%
Short % Out.2.96%
Shares Short91.61K
Short (prev mo.)61.06K
Technical
SMA 502.210 (+7.0%)
SMA 2002.505 (-5.6%)
Beta0.28
S&P 52W Chg27.94%
Avg Vol (30d)15.37K
Avg Vol (10d)25.86K
Technical Indicators
RSI (14)56.2
MACD0.0681
MACD Signal0.0612
MACD Hist.+0.0069
BB Upper2.530 USD
BB Middle2.318 USD
BB Lower2.106 USD
BB Width18.26%
ATR (14)0.1169 USD
Vol Ratio (20d)0.34x